Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Malaria vaccines based on thrombospondin-related adhesive protein of Plasmodium falciparum (Pf TRAP) are currently undergoing clinical trials in humans. This study was designed to investigate naturally acquired cellular immunity to Pf TRAP in adults from a target population for future trials of TRAP-based vaccines in Kilifi, Kenya. We first tested reactivity to a panel of 53 peptides spanning Pf TRAP and identified 26 novel T-cell epitopes. A panel of naturally occurring polymorphic variant epitope peptides were made to the most commonly recognized epitope regions and tested for ability to elicit IFN-gamma, IL-4, and IL-10 production. These data provide for the first time a complex cytokine matrix mapping naturally induced T-cell responses to TRAP and suggest that T-cell responses boosted by vaccination with Pf TRAP could stimulate the release of competing pro- and anti-inflammatory cytokines. They further define polymorphic variants able to boost specific Th1, Th2, and possibly Tr1 reactivity.

Type

Journal article

Journal

Am J Trop Med Hyg

Publication Date

03/2006

Volume

74

Pages

367 - 375

Keywords

Adult, Amino Acid Sequence, Animals, Cytokines, Enzyme-Linked Immunosorbent Assay, Epitopes, HLA-DR Antigens, Humans, Immunity, Cellular, Interferon-gamma, Interleukin-10, Interleukin-4, Kenya, Malaria Vaccines, Malaria, Falciparum, Molecular Sequence Data, Peptide Fragments, Plasmodium falciparum, Protozoan Proteins, Vaccines, Subunit